Back
Charles River Laboratories International Vs. DaVita Industry Stock Comparison
Buy
52
CRL
Charles River Laboratories International
Last Price:
221.64
Seasonality Move:
7.05%
Buy
73
DVA
DaVita
Last Price:
139.86
Seasonality Move:
3.26%
Buy
52
Charles River Laboratories International (CRL)
is a Buy
Is Charles River Laboratories International a Buy, Sell or Hold?
- The current Charles River Laboratories International [CRL] share price is $221.61. The Score for CRL is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- CRL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
73
DaVita (DVA)
is a Buy
Is DaVita a Buy, Sell or Hold?
- The current DaVita [DVA] share price is $139.82. The Score for DVA is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
- DVA is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CRL Stock Price Chart
What is Charles River Laboratories International's stock price today?
-
The Charles River Laboratories International share price today is $221.61
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRL is experiencing slight selling pressure.
CRL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.53 | Sell |
| Relative Strength Index (14 RSI): | 35.05 | Sell |
| Chaikin Money Flow: | -460013 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (227.1 - 235.62) | Sell |
| Bollinger Bands (100): | (219.78 - 257.1) | Sell |
DVA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.37 | Buy |
| Relative Strength Index (14 RSI): | 59.07 | Buy |
| Chaikin Money Flow: | 480468 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (130.84 - 139.08) | Buy |
| Bollinger Bands (100): | (111.66 - 137.24) | Buy |
CRL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 229.21 | Sell |
| 20-day SMA: | 231.57 | Sell |
| 50-day SMA: | 246.28 | Sell |
| 200-day SMA: | 218.2 | Buy |
| 8-day EMA: | 228.31 | Sell |
| 20-day EMA: | 232.33 | Sell |
| 50-day EMA: | 237.97 | Sell |
| 200-day EMA: | 226.74 | Sell |
DVA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 137.39 | Buy |
| 20-day SMA: | 136.63 | Buy |
| 50-day SMA: | 135.22 | Buy |
| 200-day SMA: | 110.05 | Buy |
| 8-day EMA: | 137.64 | Buy |
| 20-day EMA: | 136.44 | Buy |
| 50-day EMA: | 132.9 | Buy |
| 200-day EMA: | 115.23 | Buy |
Charles River Laboratories International Earnings Growth & CRL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.66 per share, a decrease next quarter of $0.11 per share, an increase this year of $0.42 per share, and an increase next year of $1.40 per share.
DaVita Earnings Growth & DVA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.66 per share, an increase next quarter of $0.13 per share, an increase this year of $1.38 per share, and an increase next year of $1.14 per share.
Charles River Laboratories International Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
DaVita Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||